Reliability and validity of a short form of the Severe Impairment Battery in Korean Alzheimer's disease patients

International Journal of Geriatric Psychiatry

Volumn 22, Issue 7, 2007, Pages 682-687

  Ahn, Inn Sook ^a   Kim, Ji Hae ^b   Saxton, Judith ^c   Kim, Doh Kwan ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Korean population; Neuropsychological test; Reliability and validity; Severe dementia; Severe Impairment Battery short form (SIB S)

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; RATING SCALE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SEVERE IMPAIRMENT BATTERY; TEST RETEST RELIABILITY; VALIDITY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DISABILITY EVALUATION; FEMALE; HUMANS; KOREA; MALE; MENTAL STATUS SCHEDULE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 34547542691     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1731     Document Type: Article

References (17)

1. Ahn IS, Kim JH, Ku HM, et al. 2006. Reliability and validity of the Severe Impairment Battery (SIB) in Korean dementia patients. J Korean Med Sci 21: 506-517.
2. Albert M, Cohen C. 1992. The test for severe impairment an instrument for assessment of patients with severe cognitive dysfunction. J Am Geriatric Soc 40: 449-453.
3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington, DC.
4. Barbarotto R, Cerri M, Acerbi C, et al. 2000. Is SIB or BNP better than MMSE in discriminating the cognitive performance of severely impaired elderly patients? Arch Neurol 15: 21-29.
5. Cossa FM, Fabiani M, Farinato A, et al. 1999. The preliminary neuropsychological battery: an instrument to grade the cognitive level of minimally responsive patients. Brain Inj 13: 583-592.
6. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State': a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12: 189-198.
7. Harrell LE, Marson D, Chatterjee A, Parrish JA. 2000. The Severe Mini-Mental State Examination: a new neuropsychologic instrument for the bedside assessment of severely impaired patients With Alzheimer disease. Alzheim Dis Assoc Disord 14: 168-175.
8. Kang Y, Na DL, Hahn S. 1997. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 15: 300-308.
9. Ku HM, Kim JH, Lee HS, et al. 2004. A Study on the reliability and validity of Seoul-Activities of Daily Living (S-ADL). J Korean Geriatr Soc 8: 206-214.
10. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
11. Morris JC. 1993. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412-2414.
12. Peavy GM, Salmon DP, Rice VA, et al. 1996. Neuropsychological assessment of severely demented elderly: the severe cognitive impairment profile. Arch Neurol 53: 367-372.
13. Reisberg B, Doody R, Stoffler A, et al. 2003. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348: 1333-1341.
14. Saxton J, McGoingle-Gibson K, Swihart A, et al. 1990. Assessment of the severely impaired patient: description and validation of a new neuropsychological test battery. Psychol Assess 2: 298-303.
15. Saxton J, Kastango KB, Hugonot-Diener L. et al. 2005. Development of a Short Form of the Severe Impairment Battery. Am J Geriatr Psychiatry 13: 999-1005.
16. Schmitt FA, Ashford W, Emesto C, et al. and the Alzheimer's Disease Cooperative Study. 1997. The Severe Impairment Battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. Alzheirner Dis Assoc Disord 11: 51-56.
17. Tariot PN, Farlow MR, Grossberg GT, et al. and the Memantine Study Group. 2004. Memantine treatment in patients with moderate-to-severe Alzheimer's disease already receiving donepezil. JAMA 291: 317-324.